Murphy Pohlad Asset Management’s GSK GSK Stock Holding History

Murphy Pohlad Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,815	Closed	-$203K	–	91
2014 Q4	$203K	Sell	3,815 -792	-17%	-$44.3K	0.15%	91
2014 Q3	$264K	Sell	4,607 -680	-13%	-$41.7K	0.2%	81
2014 Q2	$353K	Buy	5,287 +460	+10%	+$31.1K	0.27%	74
2014 Q1	$322K	Buy	4,827 +540	+13%	+$36.5K	0.26%	73
2013 Q4	$286K	Hold	4,287	–	–	0.23%	79
2013 Q3	$268K	Buy	+4,287	New	+$276K	0.24%	76

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Murphy Pohlad Asset Management's GSK Position: Q1 2015 in Review

Murphy Pohlad Asset Management sold out of GSK (GSK) in Q1 2015, closing a stake of 3,815 shares — an estimated $203K sold.

Murphy Pohlad Asset Management first reported a position in GSK in Q3 2013 and held it in 6 quarters. The position peaked at $353K in Q2 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

Murphy Pohlad Asset Management reported no remaining GSK position as of Q1 2015 after selling out during the quarter.
Murphy Pohlad Asset Management sold 3,815 GSK shares in Q1 2015, an estimated $203K.
Murphy Pohlad Asset Management first reported a position in GSK in Q3 2013 and held it in 6 quarters.
Murphy Pohlad Asset Management's GSK position peaked at $353K in Q2 2014.
740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Murphy Pohlad Asset Management's 13F filing for Q1 2015, filed 16 Apr 2015.